{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:54:52Z","timestamp":1793411692947,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["21211008"],"award-info":[{"award-number":["21211008"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["120Z920"],"award-info":[{"award-number":["120Z920"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108280","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T02:56:12Z","timestamp":1739501772000},"page":"108280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Isatin-modified Calixarene derivatives: A comprehensive study on synthesis, enzyme inhibition, antioxidant, antimicrobial, and Antiproliferative activities"],"prefix":"10.1016","volume":"157","author":[{"given":"Alev","family":"Oguz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum Nurpelin Saglik","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108280_bb0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0010","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108280_bb0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41598-023-51108-x","article-title":"Immune, metabolic landscapes of prognostic signatures for lung adenocarcinoma based on a novel deep learning framework","volume":"14","author":"Qin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108280_bb0020","article-title":"Introduction to cancer biology","author":"Hejmadi","year":"2014","journal-title":"Bookboon"},{"key":"10.1016\/j.bioorg.2025.108280_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: An overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2016.09.023","article-title":"Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities","volume":"125","author":"Akhtar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1590\/S0103-50532001000300002","article-title":"The chemistry of isatins: a review from 1975 to 1999","volume":"12","author":"Da Silva","year":"2001","journal-title":"J. Braz. Chem. Soc."},{"issue":"72","key":"10.1016\/j.bioorg.2025.108280_bb0040","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: An overview","volume":"10","author":"Heravi","year":"2020","journal-title":"RSC Adv."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108280_bb0045","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1039\/C6OB00936K","article-title":"Modern advances in heterocyclic chemistry in drug discovery","volume":"14","author":"Taylor","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108280_bb0050","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.2174\/1871520622666220404082648","article-title":"Heterocyclic Compounds: Importance in Anticancer Drug Discovery, Anti-Cancer Agents in Medicinal Chemistry","volume":"22","author":"Kumar","year":"2022","journal-title":"Formerly Current Medicinal Chemistry-Anti-Cancer Agents"},{"key":"10.1016\/j.bioorg.2025.108280_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100606","article-title":"A review on biological and medicinal impact of heterocyclic compounds","author":"Kabir","year":"2022","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.bioorg.2025.108280_bb0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.12.017","article-title":"Isatin derivatives and their anti-bacterial activities","volume":"164","author":"Guo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bmcl.2013.12.109","article-title":"1H-1, 2, 3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation","volume":"24","author":"Raj","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108280_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103505","article-title":"Click chemistry synthesis, biological evaluation and docking study of some novel 2\u2032-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents","volume":"95","author":"Boshra","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0075","doi-asserted-by":"crossref","first-page":"1900299","DOI":"10.1002\/ardp.201900299","article-title":"Isatin dimers and their biological activities","volume":"353","author":"Zhang","year":"2020","journal-title":"Arch. Pharm."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108280_bb0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1573406418666220930145336","article-title":"Isatin conjugates as antibacterial agents: A brief review","volume":"19","author":"Hassan","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128030","article-title":"Isatin-derived azoles as new potential antimicrobial agents: Design, synthesis and biological evaluation","volume":"41","author":"Tangadanchu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/antibiotics11030285","article-title":"Antimicrobial compounds from microorganisms","volume":"11","author":"Amaning Danquah","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2025.108280_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128900","article-title":"Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship","volume":"1222","author":"Nath","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108280_bb0100","first-page":"397","article-title":"Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008","volume":"9","author":"Vine","year":"2009","journal-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108280_bb0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ph15050536","article-title":"A mini review on isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs)","volume":"15","author":"Chowdhary","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108280_bb0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/1568026623666230202160925","article-title":"A Mini review on pharmacological significance of Isatin-1, 2, 3-Triazole hybrids","volume":"23","author":"Kumar","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108280_bb0115","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1039\/C7CS00163K","article-title":"Supramolecular materials","volume":"46","author":"Amabilino","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2025.108280_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.03.014","article-title":"Supramolecular biofunctional materials","volume":"129","author":"Zhou","year":"2017","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108280_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mencom.2008.09.001","article-title":"Supramolecular systems based on calixarenes","volume":"18","author":"Konovalov","year":"2008","journal-title":"Mendeleev Commun."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108280_bb0130","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1039\/b820283b","article-title":"Combining supramolecular chemistry with biology","volume":"39","author":"Uhlenheuer","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108280_bb0135","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1039\/C7CS00391A","article-title":"Drug delivery by supramolecular design","volume":"46","author":"Webber","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2025.108280_bb0140","doi-asserted-by":"crossref","unstructured":"L. Groenen, D. Reinhoudt, Calix [4] Arenes, Molecular Platforms for Supramolecular Structures, Supramolecular Chemistry, Springer1992, pp. 51\u201370.","DOI":"10.1007\/978-94-011-2492-8_4"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108280_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmc.2009.11.016","article-title":"Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands","volume":"18","author":"Mourer","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108280_bb0150","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.bmcl.2010.02.043","article-title":"Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix [4] arene scaffold","volume":"20","author":"Tsou","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108280_bb0155","doi-asserted-by":"crossref","first-page":"15298","DOI":"10.3390\/ijms232315298","article-title":"Calix[4]Resorcinarene Carboxybetaines and Carboxybetaine esters: synthesis, investigation of in vitro toxicity, anti-platelet effects, anticoagulant activity, and BSA binding affinities","volume":"23","author":"Morozova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108280_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10847-004-6715-4","article-title":"Anti-thrombotic activity of water-soluble calix [n] arenes","volume":"52","author":"Silva","year":"2005","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108280_bb0165","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14756366.2020.1765166","article-title":"Synthesis of calix [4] azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action","volume":"35","author":"Oguz","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108280_bb0170","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.bmc.2004.07.037","article-title":"Designed calix[8]arene-based ligands for selective tryptase surface recognition","volume":"12","author":"Mecca","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108280_bb0175","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.3390\/molecules28196954","article-title":"Functionalized Calixarenes as promising antibacterial drugs to face antimicrobial resistance","volume":"28","author":"Mourer","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1631-0748(02)01354-1","article-title":"Antimicrobial activity of calixarenes","volume":"5","author":"Lamartine","year":"2002","journal-title":"C. R. Chim."},{"key":"10.1016\/j.bioorg.2025.108280_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.132816","article-title":"Synthesis and anticancer activity of new p-tertbutylcalix [4] arenes integrated with trifluoromethyl aniline groups against several cell lines","volume":"116","author":"Oguz","year":"2022","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108280_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112984","article-title":"Design, synthesis and evaluation of calix [4] arene-based carbonyl amide derivatives with antitumor activities","volume":"210","author":"An","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0195","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s10637-013-9932-0","article-title":"Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer","volume":"31","author":"Dings","year":"2013","journal-title":"Investig. New Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108280_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/157016309788488302","article-title":"Calixarenes as new platforms for drug design","volume":"6","author":"de F\u00e1tima","year":"2009","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.bioorg.2025.108280_bb0205","first-page":"2831","article-title":"Applications of calixarenes in cancer chemotherapy: Facts and perspectives","author":"Yousaf","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.108280_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113733","article-title":"Balanced dual acting compounds targeting aromatase and estrogen receptor \u03b1 as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer","volume":"224","author":"Caciolla","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113511","article-title":"Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies","volume":"221","author":"Arya","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111815","article-title":"Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors","volume":"185","author":"Fantacuzzi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113737","article-title":"Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors","volume":"224","author":"Giampietro","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2016.07.016","article-title":"Synthesis, X-ray crystal structure and anti-tumor activity of calix [n] arene polyhydroxyamine derivatives","volume":"123","author":"An","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103207","article-title":"Synthesis and evaluation of the antitumor activity of calix [4] arene L-proline derivatives","volume":"94","author":"Oguz","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117586","article-title":"Novel mitochondrial and DNA damaging fluorescent calix[4]arenes bearing isatin groups as aromatase inhibitors: Design, synthesis and anticancer activity","volume":"98","author":"Oguz","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108280_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.106279","article-title":"A basket-type fluorescent sensor based calix [4] azacrown ether for multi-analytes: Practicability in living cells and real sample","volume":"167","author":"Oguz","year":"2021","journal-title":"Microchem. J."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108280_bb0250","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acsabm.8b00748","article-title":"Inclusion of quercetin in gold nanoparticles decorated with supramolecular hosts amplifies its tumor targeting properties","volume":"2","author":"Yilmaz","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioorg.2025.108280_bb0255","first-page":"234","article-title":"p-tert-Butylcalix [4] arene","volume":"68","author":"Gutsche","year":"2003","journal-title":"Org. Synth."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108280_bb0260","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1039\/p19910003137","article-title":"Chemically modified calix [4] arenes. Regioselective synthesis of 1, 3-(distal) derivatives and related compounds. X-Ray crystal structure of a diphenol-dinitrile","volume":"1","author":"Collins","year":"1991","journal-title":"J. Chem. Soc. Perkin Trans."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108280_bb0265","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1021\/ja00205a018","article-title":"Synthesis, X-ray crystal structures, and cation-binding properties of alkyl calixaryl esters and ketones, a new family of macrocyclic molecular receptors","volume":"111","author":"Arnaud-Neu","year":"1989","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108280_bb0270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jfluchem.2006.01.011","article-title":"Fluorine in medicinal chemistry: A review of anti-cancer agents","volume":"127","author":"Isanbor","year":"2006","journal-title":"J. Fluor. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:30:52Z","timestamp":1763847052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":54,"alternative-id":["S0045206825001609"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108280","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isatin-modified Calixarene derivatives: A comprehensive study on synthesis, enzyme inhibition, antioxidant, antimicrobial, and Antiproliferative activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108280"}}